Diagnosis and Management in Dementia


MARTIN / PREEDY
Diagnosis and Management in Dementia The Neuroscience of Dementia, Volume 1
910 Seiten, 1. Auflage, 2020

Offers comprehensive coverage of a broad range of topics related to dementia Serves as a foundational collection for neuroscientists and neurologists on the biology of dementia and brain dysfunction Contains in each chapter an abstract, key facts, mini dictionary of terms, and summary points to aid in understanding Provides unique sections on specific subareas, intellectual components, and knowledge-based niches that will help readers navigate key areas for research and further clinical recommendations Features preclinical and clinical studies to help researchers map out key areas for research and further clinical recommendations Serves as a "one-stop" source for everything you need to know about dementia Table of Contents: I. Dementia: Introductory Chapters and Setting the Scene 1. Mixed dementia: an overview 2. Vascular dementia: an overview 3. Small vessel disease and dementia 4. Linking Amyotrophic lateral sclerosis (ALS) and Frontotemporal dementia 5. Mortality in dementia: linking in delirium 6. Midlife diabetes and the risk of dementia- understanding the link 7. Gait and Alzheimer's disease /Gait and dementia 8. Hypertension and dementia 9. Genetics of dementia: focus on Alzheimer’s diseas 10. Clinical and pathological phenotypes in autosomal dominant frontotemporal dementia 11. Risk factors in dementia: genetic and nongenetic 12. Lipidomics and biomarker in Alzheimer’s disease 13. The 5xFAD mouse model of Alzheimer’s disease II. Biomarkers, Psychometric Instruments And Diagnosis 14. Use of cerebrospinal fluid in diagnosis of dementia 15. Salivary biomarkers in Alzheimer’s disease 16. Diacylglycerols as biomarkers in dementia 17. Butyrylcholinesterase (BChE) as a biomarker in Alzheimer’s disease 18. Blood brain-derived neurotrophic factor as a biomarker of Alzheimers disease 19. Methods of amyloid PET Imaging and its applications to Alzheimer’s disease spectrum 20. Applications of diffusion-weighted imaging (DWI) Tractography and Alzheimer’s disease 21. Transcranial Magnetic stimulation and diagnostic applications to dementias 22. Retinal imaging and dementia as a diagnostic tool 23. The prediction of Alzheimer’s disease 24. Addenbrooke's Cognitive Examination 25. The Montreal Cognitive Assessment (MoCA) and applications to dementia 26. ALBA Screening Instrument (ASI) and applications to dementia 27. The Quick Mild Cognitive Impairment (Qmci) screen and applications to dementia 28. Assessment of activities of daily living (ADL) applied to dementia III. Pharmacological Treatments For Dementia 29. Cholinesterase inhibitors in dementias: an overview 30. Choline-containing phospholipids and treatment of adult-onset dementia disorders 31. Donepezil usage: a focused review 32. Memantine: a focused review 33. The benefits of calcium channel blockers for the therapy of dementia 34. Pitfalls for pharmacotherapeutic trials in dementia 35. All-trans retinoic acid in Alzheimer’s disease 36. Dementias and usage of NMDA receptor antagonists 37. Dementia and bladder dysfunction: a focus on treatments with anticholinergics 38. Linking astrocytes' exosomes to Alzheimer's pathogenesis and therapy 39. Changing the fate: therapeutic mechanisms focus on the switch of beta-amyloid precursor protein (APP) processing 40. Acetylcholinesterase inhibitory agents in plants and application to dementia: Alzheimers Disease 41. Removal of blood amyloid as a safety strategy IV. Non-Pharmacological Treatments and Procedures 42. Caring for people with Dementia in the Acute Hospital 43. Environmental enrichment in dementia 44. Music therapy in dementia 45. Aromatherapy in dementia 46. Dancing in dementia 47. Hypoxic-hyperoxic training and dementia 48. Linking amyloid and depression in dementia: effects of treatments by non-drug means 49. Regional dementia care networks 50. Cognitive behavioural therapy (CBT) use in Alzheimer’s disease 51. Maximizing cognition in Mild Cognitive Impairment and early-stage dementia 52. Exercise, cognitive creativity, and dementia 53. Linking care staff, person-focused communications and dementias

ca. € 175,00


versandkostenfrei - in 8 bis 14 Werktagen lieferbar	Anzahl:

Preis: ca. € 175,00